Category: Lymphoma News

Lymphoma and PTSD Study: Participants Still Needed

Update: this study is closed to enrollment. 

The “Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress)” study is still looking for participants to complete recruitment.

The study, conducted at Weill Cornell Medical College, is looking at Post-traumatic Stress Disorder (PTSD) and Post-traumatic Growth in patients diagnosed with Lymphoma (Non-Hodgkin’s, Hodgkin’s, or Waldenstrom’s Macroglobulinemia). Here is a brief description of the study:

We are looking to see if we can find which patients are more likely to develop PTSD, which patients are more likely to develop Post-traumatic Growth, and we are also looking to see if there is a correlation between the two.

Any patient with a diagnosis of Lymphoma including Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma, or Waldenstrom’s Macroglobulinemia is welcome to participate, regardless of treatment history. The interview will be approximately 60-90 minutes and is given in survey form. This can be completed in-person, over the phone, via mail, or via internet-based surveys.

Click here for more information, including the background to the study, or contact Dr. Regina Jacob at (646) 962-5027 or rej2008@med.cornell.edu.

Dr. John Leonard Discusses Antibody Therapy in Lymphoma

Weill Cornell’s Dr. John Leonard discusses antibody therapy in lymphoma in a Medscape CME program. Click here to view the presentation.

 

 

 

Weill Cornell Among Recipients of $50 Million Stem Cell Research Grant

The Starr Foundation is is making a $50 million gift in support of the Tri-Institutional Stem Cell Initiative (Tri-SCI), which was established through a grant from the Foundation in 2005. The new gift is awarded to the original Tri-SCI members — Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, The Rockefeller University. The grant will support and enhance collaborative, pioneering stem cell research at the three adjacent Manhattan campuses. The laboratories are investigating the properties of embryonic stem cells, which have the potential to differentiate into any cell type in the body, and adult stem cells, which are found in various tissues and can give rise to specific cell types. These studies are opening new avenues for understanding a range of health conditions, including developmental disorders, neurodegenerative diseases and cancer.

Click here to read the full press report on the grant.